Arkadios Wealth Advisors’s Boston Scientific BSX Stock Holding History

Arkadios Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Sell	9,370 -37,240	-80%	-$2.02M	0.01%	1239
2026 Q1	$2.92M	Buy	46,610 +1,850	+4%	+$148K	0.05%	395
2025 Q4	$4.27M	Buy	44,760 +7,024	+19%	+$689K	0.08%	257
2025 Q3	$3.68M	Buy	37,736 +16,996	+82%	+$1.76M	0.09%	240
2025 Q2	$2.23M	Buy	20,740 +1,606	+8%	+$162K	0.07%	319
2025 Q1	$1.93M	Buy	+19,134	New	+$1.93M	0.07%	291
2021 Q4	–	Sell	-356	Closed	-$15K	–	738
2021 Q3	$15K	Hold	356	–	–	﹤0.01%	1311
2021 Q2	$15K	Hold	356	–	–	﹤0.01%	1394
2021 Q1	$13K	Buy	+356	New	+$13.5K	﹤0.01%	1097
2020 Q3	–	Sell	-49	Closed	-$1.73K	–	1031
2020 Q2	$1.73K	Buy	49 +25	+104%	+$900	﹤0.01%	878
2020 Q1	$783	Buy	+24	New	+$938	﹤0.01%	985

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arkadios Wealth Advisors's BSX Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Boston Scientific (BSX) stake by 80% in Q2 2026, selling an estimated $2.02M and leaving 9,370 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #1239.

Arkadios Wealth Advisors first reported a position in BSX in Q1 2020 and has held it in 11 quarters since. The position peaked at $4.27M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Arkadios Wealth Advisors held 9,370 shares of Boston Scientific worth $400K as of Q2 2026.
Arkadios Wealth Advisors sold 37,240 Boston Scientific shares in Q2 2026, an estimated $2.02M.
Boston Scientific made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1239 holding.
Arkadios Wealth Advisors first reported a position in Boston Scientific in Q1 2020 and has held it in 11 quarters since.
Arkadios Wealth Advisors's Boston Scientific position peaked at $4.27M in Q4 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.